Results 241 to 250 of about 2,138,197 (387)

A Rare Case of Fluid Overload-Associated Large B-Cell Lymphoma in a Patient With Hepatitis C Cirrhosis. [PDF]

ACG Case Rep J
Shelukar S, Agarwal A, Gross J, Truscello D, Flerova E, Gesiotto Q, Alpdogan O, Civan JM, Sass DA.   +8 more
europepmc   +1 more source

Case Report of Cutaneous Large B-cell leg-type Lymphoma in Young Woman

, 2019
Mounia Bendari, S. Laajouri, S Cherkaoui, Mouna Lamchahab, A. Quessar, Nisrine Khoubila   +5 more
openalex   +1 more source

Detection of elevated levels of tumour‐associated microRNAs in serum of patients with diffuse large B‐cell lymphoma

British Journal of Haematology, 2008
C. Lawrie, S. Gal, Heather M. Dunlop, Beena Pushkaran, A. Liggins, K. Pulford, A. Banham, F. Pezzella, J. Boultwood, J. Wainscoat, C. Hatton, A. Harris   +11 more
semanticscholar   +1 more source

Trojan Horse Strategy: How Biomimetic Nanomedicine Remodels the Tumor Microenvironment

Advanced Science, EarlyView.
This review focuses on biomimetic nanomedicines for tumor microenvironment (TME) remodeling, covering their diverse biomimetic types, design principles, and mechanisms of immune cell reprogramming and reversal of immunosuppressive microenvironments, with particular emphasis on their application in synergistic immunotherapy.
Wanrong Wang, Siqi Mu, Juan Zhang, Guisong Shan, Xueqian Li, Ran Wang, Tao Guo, Xiaoyan He   +7 more
wiley   +1 more source

Retreatment with R-CHOP-like therapy in patients with late relapse of diffuse large B-cell lymphoma. [PDF]

Blood Adv
Champagne JN, Villa D, Gerrie AS, Venner CP, Slack GW, Farinha P, Craig JW, Hilton LK, Savage KJ, Scott DW, Sehn LH.   +10 more
europepmc   +1 more source

Faculty Opinions recommendation of IL-12 upregulates TIM-3 expression and induces T cell exhaustion in patients with follicular B cell non-Hodgkin lymphoma.

, 2012
Larry Kane, Judong Lee
openalex   +2 more sources

An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era.

Blood, 2014
Zheng Zhou, L. Sehn, A. Rademaker, L. Gordon, A. LaCasce, Allison Crosby‐Thompson, A. Vanderplas, A. Zelenetz, G. Abel, M. Rodriguez, A. Nademanee, M. Kaminski, M. Czuczman, M. Millenson, J. Niland, R. Gascoyne, J. Connors, J. Friedberg, J. Winter   +18 more
semanticscholar   +1 more source

Direct Extracellular Matrix Modulation Attenuates Intestinal Fibrosis via a Fibronectin‐Targeted Approach

Advanced Science, EarlyView.
Fibronectin regulates the extracellular matrix (ECM)–myofibroblast cycle through three key steps: (1) its secretion and assembly by myofibroblasts (inhibited by pUR4); (2) collagen deposition along its scaffold (inhibited by R1R2); and (3) integrin α5β1‐mediated mechanotransduction (inhibited by ATN161).
Wenlong Ma, Siyu Yang, Tengkai Wang, Di Zhang, Hewei Wu, Shichen Fu, Xiaohan Wan, Lixiang Li, Xiuli Zuo, Yanqing Li, Jiaoyang Lu   +10 more
wiley   +1 more source

CRISPR‐Cas9‐Loaded Theranostic Liposomes for Enhancing Radiosensitization of Prostate Cancer through POLD4 Gene Editing under Real‐Time MRI Monitoring

Advanced Science, EarlyView.
This study identifies POLD4 as a potential prostate cancer radiosensitization target through transcriptome sequencing. By encapsulating POLD4‐targeted CRISPR/Cas9 plasmids and USPIONs in cationic liposomes, an MRI‐monitored gene‐editing platform is established.
Xuhui Fan, Ruru Zhang, Linjun Yang, Shixiong Chen, Meijuan He, Yongqiang Wang, Linjie Huang, Jianfeng Zeng, Shuwang Wu, Mingyuan Gao, Han Wang   +10 more
wiley   +1 more source

Clinical and pathological analysis of intravascular large B-cell lymphoma of the prostate. [PDF]

Discov Oncol
Zhao J, Li L, Yang J, Peng J, Li C.
europepmc   +1 more source